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LETTERS TO THE EDITOR
Adrenocorticotropic Hormone (ACTH) But Not
Alpha-Melanocyte Stimulating Hormone (a-MSH) as a
Mediator of Adrenalectomy Induced Hair Growth in Mink
To the Editor:
In the mink (Mustela vison), winter hair growth (anagen) usually begins
in mid-September in response to reduced photoperiod, whereas summer
anagen begins in late April as the photoperiod increases. We have
demonstrated that bilateral adrenalectomy (ADX) during the resting
(telogen) stage of either the summer or the winter hair growth cycle
initiates anagen 4–5 wk earlier than controls (Rose and Sterner, 1992;
Rose, 1995). The mechanism for ADX induced hair growth is
unknown, although Paus et al (1994b) demonstrated a localized anagen
response in the mouse 12 d after two intradermal injections of
adrenocorticotropic hormone (ACTH). Because pituitary secretion of
ACTH would be expected to increase following ADX, it is possible
that ADX induced hair growth is mediated through this hormone;
however, because blood ACTH levels fluctuate in response to many
forms of stress, it seems unlikely that pituitary ACTH would function
as a regulator of hair growth cycles under normal physiologic conditions.
Nevertheless, ACTH, alpha-melanocyte stimulating hormone
(α-MSH), and other proopiomelanocortin derived peptides and their
receptors are synthesized by the skin (Slominski et al, 1992, 1996a;
Wintzen and Gilchrest, 1996; Luger et al, 1997). In addition, Slominski
et al (1992, 1996b) illustrated that expression of the proopiomelanocortin
gene was higher during anagen than telogen in the skin of mice.
The objective of this study was to determine if ACTH and/or
α-MSH would induce anagen in mink that were in summer telogen.
On July 1 1997, eight adult female mink were housed in individual
cages in a light tight room and exposed to a photoperiod approximating
natural changes in day length. After shearing the fur over the lower
half of the dorsal surface, four mink were injected intradermally in the
right flank region with α-MSH (Peninsula Laboratories, Belmont, CA)
at 5.0 3 10–5 M in 500 µl of phosphate buffered saline (PBS) on July
21, 23, and 25. On the same days, an additional four mink were
injected intradermally in the left flank with ACTH (Sigma, St. Louis,
MO) at the same concentration. The contralateral side of each mink
was injected with PBS. Subsequently, the mink were observed daily
for the appearance of blue pigmentation at the injection site as evidence
of anagen onset.
On August 12, 18 d after the last injection, a dark blue spot was
observed in all ACTH treated mink over the injection site only,
whereas no α-MSH treated mink exhibited a change in pigmentation.
On August 28 all ACTH treated mink exhibited hair growth averaging
4 mm over the injection site (Fig 1A). None of the α-MSH treated
mink exhibited hair growth over the injection site, although two
animals did display hair growth over the spinal column (probably due
to scraping the skin with shears), one of which had rather well
developed guard hair growth over the entire sheared area (Fig 1B).
We inadvertently injected the ACTH treatment group on the right
and left side with ACTH on July 23; however, as can be seen,
the single injection of ACTH was clearly not sufficient to induce
hair growth.
These findings suggest to us that ADX induced anagen in mink
occurs as a result of elevated ACTH that acts directly on the skin.
This most likely explains why ADX induces anagen during both
summer and winter telogen. The fact that α-MSH did not induce hair
growth or pigmentation suggests that this peptide is not involved in
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Figure 1. Anagen response to intradermal injections of ACTH or
a-MSH. Mink were injected intradermally in the left flank with ACTH (A)
or in the right flank with α-MSH (B) at 5.0 3 10–5 M in PBS once daily on
July 21, 23, and 25 1997. The contralateral hip of each mink was injected with
PBS only. The response pictured was on August 28, 34 d after the last injection.
anagen initiation and/or that ACTH and α-MSH act through separate
receptors in mink skin. The mechanism for ACTH induced anagen
remains to be determined although it seems reasonable to ask: Does
ACTH influence the metabolism of steroid hormones in the skin in a
manner akin to that of the adrenal gland? The dermal papilla of the
hair follicle (essential for anagen induction) and adrenal cortex are both
derived from mesenchyme. Skin is a highly steroidogenic tissue,
metabolizing androgens and estrogens, both of which have been shown
to have profound effects on hair growth cycles. Moreover, Slominski
et al (1996a) recently demonstrated that the gene for cytochrome
P450c21, which produces 11-deoxycorticosterone and 11-deoxycorti-
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sol (precursors to corticosterone and cortisol, respectively), was
expressed in human skin. The possibility of glucocorticoid production
in the skin coupled with the observations that topical corticoids block
the development of anagen (Stenn et al, 1993), suppress proopiomelano-
cortin expression (Ermak and Slominski, 1997), and induce follicular
regression (Paus et al, 1994a), should attract more intense research
efforts in this area. Perhaps in species like the mink, which display
photoperiodically controlled hair growth cycles, the onset of anagen
occurs, in part, as a result of the seasonal production of ACTH and
the subsequent metabolism of steroid hormones, both of which occur
within the skin. Such a phenomenon might also contribute to the
development of different pelage types such as dense winter fur and
sparse summer fur as a result of differential activation of under hair
type fibers. Adrenalectomized animals such as the mink should provide
an excellent model with which to investigate the role of endogenous
ACTH in hair growth cycles.
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Inhibition of Chemotherapy-Induced Keratinocyte Apoptosis
In Vivo by an Interleukin-15-IgG Fusion Protein
To the Editor:
The control of keratinocyte apoptosis in vivo under physiologic and
pathologic conditions is still quite unclear. During spontaneous or
induced regression of the hair follicle, remodelling is largely brought
about by the massive, yet highly controlled apoptosis of keratinocytes
in the proximal follicle epithelium (Weedon and Strutton, 1981). The
hair follicle therefore offers an ideal, yet often ignored model system
for studying the control of keratinocyte apoptosis in situ (Paus et al,
1993; Lindner et al, 1997).
Among the secreted signals that could serve to downregulate
keratinocyte apoptosis in situ (Polakowska and Haake, 1994; White,
1996), interleukin-15 (IL-15) has recently surfaced as an especially
intriguing candidate because it suppresses multisystem apoptosis induced
by anti-Fas antibodies in mice as well as anti-Fas and dexamethasone-
induced apoptosis in T and B cells in vitro (Bulfone-Paus et al, 1997).
Furthermore, anti-Fas-induced lethal multisystem apoptosis in mice is
suppressed by an IL-15-IgG2b fusion protein (FP), resulting in the
survival of all IL-15 FP treated mice (Bulfone-Paus et al, 1997). These
data raise the possibility that IL-15 may also inhibit keratinocyte
apoptosis.
The massive upregulation of keratinocyte apoptosis that is associated
with chemotherapy-induced follicle dystrophy and alopecia (Lindner
et al, 1997) is well suited to detect apoptosis-suppressing effects of
candidate agents. Using a mouse model for the study of chemotherapy-
Reprint requests to: Dr. Ralf Paus, Cherite´, Department of Dermatology,
Humboldt University, Schumannstr. 20/21, D-10117 Berlin, Germany.
Abbreviations: CYP, cyclophosphamide; FP, fusion protein.
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induced alopecia and follicle dystrophy (Paus et al, 1994), we have
addressed the question of whether cyclophosphamide (CYP)-induced
apoptosis of keratinocytes in the hair bulb of anagen VI follicles in vivo
is down-modulated by prior administration of IL-15-IgG2b FP (for
details see Bulfone-Paus et al, 1997). As controls, either CYP alone or
CYP and an IL-2-IgG2b FP (Kunzendorf et al, 1996) were injected,
because keratinocytes do not express IL-2 receptors.
Twenty-four hours after the intraperitoneal injection of 120 mg
CYP per kg into C57BL/6 mice with all back skin hair follicles in
early anagen VI (Paus et al, 1994), with or without coadministration
of 100 µg IL-15-IgG2b FP (Bulfone-Paus et al, 1997) or IL-2-IgG2b
FP (Kunzendorf et al, 1996), back skin cryosections were prepared and
stained for apoptotic cells, using a fluorescent TUNEL method with
a commercially available in situ end-labeling kit (ApoptagR, Oncor,
Gaithersburg, MD), combined with counterstaining by Hoechst 33342
(Lindner et al, 1997).
The number of TUNEL1 keratinocytes in the proximal hair bulb
of anagen VI follicles with the characteristic Hoechst 33342 morphology
of apoptotic cells was quantitated and compared between CYP, CYP
1 IL-15-IgG2b, and CYP 1 IL-2-IgG2b FP treated mice.
A single administration of the IL-15-IgG2b FP (100 µg), but not of
the control IL-2-IgG2b FP, inhibited CYP-induced keratinocyte
apoptosis in murine anagen hair bulbs in vivo (Figs 1, 2). This inhibitory
effect was discrete (reduction by µ24%), but statistically significant
(p , 0.001), when the total number of apoptotic cells in CYP– versus
CYP 1 IL-15-IgG FP treated hair follicles was compared by quantitative
histomorphometry (Fig 2).
Whereas the mechanisms underlying this apoptosis-inhibitory
property of an IL-15-IgG FP remain to be elucidated, these data
demonstrate that, in the current model, stimulation of the IL-15
